Current status: 974 hESC lines, 6269 hiPSC lines, and 153 clinical studies, and 2320 certificates
Monthly statistic from Jul 1, 2024
Posted on July 1, 2024
total lines | 7243 |
hESC lines | 974 |
hiPSC lines | 6269 |
derivation countries | 48 |
projects | 303 |
providers | 912 |
clinical studies | 153 |
subclones | 2882 |
certificates | 2320 |
cell line certificates | 2175 |
project certificates | 145 |